Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Juan José Bretón"'
Autor:
Manuel Cobo, Raquel Delgado, Silvia Gil, Ismael Herruzo, Víctor Baena, Francisco Carabante, Pilar Moreno, José Luis Ruiz, Juan José Bretón, M. José, null del Rosal, Carlos Fuentes, Paloma Moreno, Emilio García, Esther Villar, Jorge Contreras, Inmaculada Alés, Manuel Benavides
Publikováno v:
Clinical and Translational Oncology. 8:903-911
Organ preservation has been investigated in patients (p) with infiltrating transitional cell carcinoma (TCC) of the bladder over the past decade as an alternative to radical cystectomy. This is a trimodal schedule study, including transurethral resec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3cfa858b0f98d0a75509e8275a720d4d
https://doi.org/10.1007/s12094-006-0154-1
https://doi.org/10.1007/s12094-006-0154-1
Autor:
Juan José Bretón García, Joan Maurel Santasusana, Pedro Sánchez Rovira, Javier Sastre Valera, Ignacio García Ribas, Javier Gallego Plazas, F. J. Delgado, Alfredo Carrato Mena, Jesús Florián Jericó, Ana Isabel León Carbonero, José Luis García López, Javier Casinello Espinosa, Enrique Aguilar, Marta Llanos Muñoz, Carlos Fernández Martos, Ma Carmen Galán Guzmán
Publikováno v:
Clinical and Translational Oncology. 7:493-498
A multi-centred, open-labelled, phase II study containing 46 patients was conducted to evaluate the clinical benefit of gemcitabine (1,400 mg/m2) combined with 5-FU (3 g/m2) in a 48 h continuous infusion (CI). Both drugs were administered on days 1,8
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6a6d01fa45ed60f1794d6675afa05402
https://doi.org/10.1007/bf02717002
https://doi.org/10.1007/bf02717002
Autor:
Ismael Herruzo Cabrera, Antonio Sacchetti de Passos, Juan José Bretón García, José Antonio Medina Carmona, Isabel García Ríos, Manuel Cobo Dolls, Isabel Sevilla García, Emilio Alba Conejo
Publikováno v:
Clinical and Translational Oncology. 6:81-85
Introduccion El uso de quimioterapia y radioterapia en el cancer microcitico de pulmon (SCLC) mejora el control local y la supervivencia.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f1322a5f3c9f3b1601e0b823ba399e99
https://doi.org/10.1007/bf02710032
https://doi.org/10.1007/bf02710032
Autor:
Elena Filipovich Vegas, Bartolomeu Massuti Sureda, Alejandro Tres Sánchez, José Ignacio Mayordomo Cámara, Raquel Andrés Conejero, José Anadrés Meana García, Dolores Isla Casado, Remedios Blanco Guerrero, Carmen Santander Lobera, Manuel Valladares Ayerbes, Juan José Bretón García, Jesús Florián Jericó
Publikováno v:
Revista de Oncología. 5:79-87
Fundamento Se ha descrito una importante actividad (50% de respuestas objetivas) con un pequeno numero de supervivientes en los ensayos clinicos de quimioinmunoterapia (QIT) para el melanoma diseminado. En la mayoria, la hospitalizacion era un requer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::87341592d0c9241eaec5cd2f7003e349
https://doi.org/10.1007/bf02728200
https://doi.org/10.1007/bf02728200
Publikováno v:
Clinicaltranslational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. 12(7)
Clinical scenarios associated with low therapeutic effectiveness (LTE) are especially complex and highly relevant in oncology. The objective was to test a methodological framework for creating consensual clinical recommendations for routine practice.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c0e62968e8691307bc263483a94f9ede
https://pubmed.ncbi.nlm.nih.gov/20615826
https://pubmed.ncbi.nlm.nih.gov/20615826
Autor:
Julia Alcalde García, Francisco Carabantes Ocón, Inmaculada Alés Díaz, Manuel Benavides Orgaz, Vanesa Gutiérrez Calderón, Silvia Gil Calle, Esther Villar Chamorro, Alvaro Montesa Pino, Juan José Bretón García, Manuel Cobo Dols
Publikováno v:
Clinicaltranslational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. 8(10)
Objective. We conducted this phase II trial to evaluate the efficacy and toxicity of the sequential nonplatinum combination chemotherapy consisting of gemcitabine (GEM) and vinorelbine (VNR) followed by weekly docetaxel (DOC) in patients with advance
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cd6308a0c704fdab08166f04f633785c
https://pubmed.ncbi.nlm.nih.gov/17074673
https://pubmed.ncbi.nlm.nih.gov/17074673
Autor:
María Gabriela Ramírez Arriola, Naima Hamido Mohamed, Juan José Abad Vivás-Pérez, Juan José Bretones Alcaráz, Juan Manuel García Torrecillas, Evelyn Huber
Publikováno v:
Atención Primaria, Vol 49, Iss 2, Pp 86-92 (2017)
Objetivo: Describir las características de la cirugía menor (CM) en un centro de atención primaria (AP) evaluando la concordancia anatomopatológica y clínica, así como la satisfacción del paciente. Diseño: Estudio descriptivo y retrospectivo.
Externí odkaz:
https://doaj.org/article/ab9f1304efc44edc836479c2bd71cb7c